Worldwide healthcare management for a variety of chronic conditions is managed reactively, wait until symptoms change and then act. Kitea Health are wanting to change the management of patients to one of proactive care. They do this through precise monitoring of pressure within the body via micro-implantable devices.  They believe micro-implants are the next generation of implantable technologies that will enable people to remain in their own homes and out of hospital yet have their health needs better managed at lower cost.

This next generation medical device company was founded by Simon Malpas and is headquartered in Auckland.  Founded from the Auckland Bioengineering Institute with substantial backing for its research platform from the Health Research Council, Ministry of Business Innovation and Employment and a variety of charitable bodies. The company is currently in the preclinical stage for its first clinical device for the management of hydrocephalus.

Read more here.